• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迷迭香酸-β-氨基-α-酮酰胺杂化物作为抗利什曼原虫剂的设计、合成及用途拓展

Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents.

作者信息

Hassan Ahmed H E, Bayoumi Waleed A, El-Sayed Selwan M, Phan Trong-Nhat, Oh Taegeun, Ham Gyeongpyo, Mahmoud Kazem, No Joo Hwan, Lee Yong Sup

机构信息

Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt.

Medicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.

出版信息

Pharmaceuticals (Basel). 2023 Nov 12;16(11):1594. doi: 10.3390/ph16111594.

DOI:10.3390/ph16111594
PMID:38004459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10675174/
Abstract

A series of rosmarinic acid-β-amino-α-ketoamide hybrids were synthesized and rationally repurposed towards the identification of new antileishmanial hit compounds. Two hybrids, and showed promising activity (IC values of 9.5 and 8.8 μM against promastigotes, respectively). Their activities were comparable to erufosine. In addition, cytotoxicity evaluation employing human THP-1 cells revealed that the two hybrids and possess no cytotoxic effects up to 100 µM, while erufosine possessed cytotoxicity with CC value of 19.4 µM. In silico docking provided insights into structure-activity relationship emphasizing the importance of the aliphatic chain at the α-carbon of the cinnamoyl carbonyl group establishing favorable binding interactions with CALP and ARG in both hybrids and . In light of these findings, hybrids and are suggested as potential safe antileishmanial hit compounds for further development of anti-leishmanial agents.

摘要

合成了一系列迷迭香酸-β-氨基-α-酮酰胺杂合物,并对其进行合理改造,以鉴定新的抗利什曼原虫活性化合物。两种杂合物, 和 表现出有前景的活性(对前鞭毛体的IC值分别为9.5和8.8 μM)。它们的活性与依鲁替尼相当。此外,用人THP-1细胞进行的细胞毒性评估显示,两种杂合物 和 在高达100 μM时均无细胞毒性作用,而依鲁替尼具有细胞毒性,CC值为19.4 μM。计算机模拟对接提供了对构效关系的见解,强调了肉桂酰羰基α-碳上脂肪链的重要性,该脂肪链在两种杂合物 和 中与CALP和ARG建立了有利的结合相互作用。鉴于这些发现,杂合物 和 被建议作为潜在的安全抗利什曼原虫活性化合物,用于抗利什曼原虫药物的进一步开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/52611624890d/pharmaceuticals-16-01594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/b5ed40a036ff/pharmaceuticals-16-01594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/2fb91b44491c/pharmaceuticals-16-01594-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/de988ed85668/pharmaceuticals-16-01594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/6322fde85a78/pharmaceuticals-16-01594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/52611624890d/pharmaceuticals-16-01594-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/b5ed40a036ff/pharmaceuticals-16-01594-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/2fb91b44491c/pharmaceuticals-16-01594-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/de988ed85668/pharmaceuticals-16-01594-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/6322fde85a78/pharmaceuticals-16-01594-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f69/10675174/52611624890d/pharmaceuticals-16-01594-g004.jpg

相似文献

1
Design, Synthesis, and Repurposing of Rosmarinic Acid-β-Amino-α-Ketoamide Hybrids as Antileishmanial Agents.迷迭香酸-β-氨基-α-酮酰胺杂化物作为抗利什曼原虫剂的设计、合成及用途拓展
Pharmaceuticals (Basel). 2023 Nov 12;16(11):1594. doi: 10.3390/ph16111594.
2
Rational repurposing, synthesis, and studies of chromone-peptidyl hybrids as potential agents against .理性再利用、合成及色酮-肽类杂合体作为潜在. 抑制剂的研究
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2229071. doi: 10.1080/14756366.2023.2229071.
3
Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies.作为抗利什曼原虫活性物质的贝司他汀类似物 - 4 - 喹啉酮杂合物:设计、重新利用的合理性、合成、体外和计算机模拟研究
Eur J Med Chem. 2023 Mar 15;250:115211. doi: 10.1016/j.ejmech.2023.115211. Epub 2023 Feb 14.
4
Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.新型β-咔啉-喹唑啉酮杂合体破坏利什曼原虫的氧化还原平衡,并显示出有希望的抗利什曼原虫活性。
Biochem Pharmacol. 2017 Apr 1;129:26-42. doi: 10.1016/j.bcp.2016.12.012. Epub 2016 Dec 22.
5
Synthesis of Thiocarbohydrazones and Evaluation of their in vitro Antileishmanial Activity.硫代碳腙的合成及其体外抗利什曼原虫活性评估
Med Chem. 2018;14(7):725-732. doi: 10.2174/1573406414666180115094630.
6
Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.N-取代四氢-β-咔啉的合成、抗利什曼原虫和抗锥虫活性
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3247-50. doi: 10.1016/j.bmcl.2014.06.030. Epub 2014 Jun 18.
7
β-Nitrostyrenes as Potential Anti-leishmanial Agents.β-硝基苯乙烯作为潜在的抗利什曼原虫药物。
Front Microbiol. 2016 Sep 1;7:1379. doi: 10.3389/fmicb.2016.01379. eCollection 2016.
8
Design, Rational Repurposing, Synthesis, In Vitro Evaluation, Homology Modeling and In Silico Study of Sulfuretin Analogs as Potential Antileishmanial Hit Compounds.硫磺素类似物作为潜在抗利什曼原虫活性化合物的设计、合理再利用、合成、体外评价、同源建模和计算机模拟研究
Pharmaceuticals (Basel). 2022 Aug 26;15(9):1058. doi: 10.3390/ph15091058.
9
Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction.新型吲哚基香豆素杂化物的抗利什曼原虫活性:设计、合成、生物学评价、分子对接研究及计算机辅助ADME预测
Bioorg Med Chem Lett. 2016 Feb 1;26(3):829-835. doi: 10.1016/j.bmcl.2015.12.085. Epub 2015 Dec 24.
10
Synthesis, Structure and Antileishmanial Evaluation of Endoperoxide-Pyrazole Hybrids.合成、结构与过氧化物-吡唑杂合体的抗利什曼原虫活性评价。
Molecules. 2022 Aug 24;27(17):5401. doi: 10.3390/molecules27175401.

引用本文的文献

1
Discovery of Cyclopentane-Based Phospholipids as Miltefosine Analogs with Superior Potency and Enhanced Selectivity Against .发现基于环戊烷的磷脂作为米替福新类似物,具有更高的效力和对……更强的选择性。
Pharmaceuticals (Basel). 2025 Jun 30;18(7):984. doi: 10.3390/ph18070984.
2
Design, synthesis and evaluation of acetylcholine-antitumor lipid hybrids led to identification of a potential anticancer agent disrupting the CDK4/6-Rb pathway in lung cancer.乙酰胆碱 - 抗肿瘤脂质杂化物的设计、合成与评估,促成了一种潜在抗癌药物的鉴定,该药物可破坏肺癌中的CDK4/6 - Rb信号通路。
RSC Med Chem. 2025 Mar 7. doi: 10.1039/d4md01007h.

本文引用的文献

1
Rational repurposing, synthesis, and studies of chromone-peptidyl hybrids as potential agents against .理性再利用、合成及色酮-肽类杂合体作为潜在. 抑制剂的研究
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2229071. doi: 10.1080/14756366.2023.2229071.
2
Design, synthesis, and repurposing of O-aminoalkyl-sulfuretin analogs towards discovery of potential lead compounds as antileishmanial agents.O-氨基烷基硫黄菊素类似物的设计、合成及重新利用,以发现作为抗利什曼原虫剂的潜在先导化合物。
Eur J Med Chem. 2023 May 5;251:115256. doi: 10.1016/j.ejmech.2023.115256. Epub 2023 Mar 9.
3
Drug Repurposing: An Effective Tool in Modern Drug Discovery.
药物再利用:现代药物发现中的一种有效工具。
Russ J Bioorg Chem. 2023;49(2):157-166. doi: 10.1134/S1068162023020139. Epub 2023 Feb 21.
4
Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies.作为抗利什曼原虫活性物质的贝司他汀类似物 - 4 - 喹啉酮杂合物:设计、重新利用的合理性、合成、体外和计算机模拟研究
Eur J Med Chem. 2023 Mar 15;250:115211. doi: 10.1016/j.ejmech.2023.115211. Epub 2023 Feb 14.
5
Molecular Hybridization Strategy on the Design, Synthesis, and Structural Characterization of Ferrocene--acyl Hydrazones as Immunomodulatory Agents.基于分子杂交策略设计、合成及结构表征二茂铁酰腙类化合物作为免疫调节剂
Molecules. 2022 Nov 30;27(23):8343. doi: 10.3390/molecules27238343.
6
The Time and Place for Nature in Drug Discovery.药物研发中自然的时机与地位。
JACS Au. 2022 Oct 14;2(11):2400-2416. doi: 10.1021/jacsau.2c00415. eCollection 2022 Nov 28.
7
Natural products and drug discovery.天然产物与药物发现
Natl Sci Rev. 2022 Sep 29;9(11):nwac206. doi: 10.1093/nsr/nwac206. eCollection 2022 Nov.
8
Current leishmaniasis drug discovery.当前利什曼病药物研发
RSC Med Chem. 2022 Aug 26;13(9):1029-1043. doi: 10.1039/d1md00362c. eCollection 2022 Sep 21.
9
Visceral Leishmaniasis: Epidemiology, Diagnosis, and Treatment Regimens in Different Geographical Areas with a Focus on Pediatrics.内脏利什曼病:不同地理区域的流行病学、诊断及治疗方案,重点关注儿科
Microorganisms. 2022 Sep 21;10(10):1887. doi: 10.3390/microorganisms10101887.
10
Design, Rational Repurposing, Synthesis, In Vitro Evaluation, Homology Modeling and In Silico Study of Sulfuretin Analogs as Potential Antileishmanial Hit Compounds.硫磺素类似物作为潜在抗利什曼原虫活性化合物的设计、合理再利用、合成、体外评价、同源建模和计算机模拟研究
Pharmaceuticals (Basel). 2022 Aug 26;15(9):1058. doi: 10.3390/ph15091058.